Drug Formulary Review Archives – August 1, 1998
August 1, 1998
View Issues
-
Team decreases hypertension meds by 22.3% using JNC-VI guides
-
HT after JNC-VI: Cut costs with early HT control
-
Hypertension treatment still an empirical dilemma
-
Here are the latest studies in hyptension
-
FACET trials boosts status of ACE inhibitors
-
Charting the maze of hypertension treatment
-
Lyme disease vaccine pushed by FDA
-
NABP to publicize pharmacist censure
-
HCFA proposal draws criticism
-
New thrombolytic praised for effectiveness
-
FDA completes drug list for pediatric oversight